Symposium 12: Challenges and approaches toPharmacoepidemiologic research in mental healthModerator
Soko Setoguchi FISPE, Rutgers University, USA
Soko Setoguchi, MD, DrPH, FISPE, a cardiologist by training, US boardcertified internist, and pharmacoepidemiologist, is Associate Professorof Medicine and Epidemiology, Director of Clinical Research Education,
Department of Medicine, Rutgers Robert Wood Johnson Medical School
and Co-Director of the Master of Science in Clinical and Translational
Science at Rutgers School of Graduate Studies. After her medical schooland Cardiology training in Japan, she completed her doctoral training in
epidemiology at the Harvard School of Public Health. Dr. Setoguchi isrecognized as an international leader in the field ofpharmacoepidemiology. She has authored more than 120 peer-reviewed
papers, and has successfully obtained federal and non-federal grants forher pharmacoepidemiology research program. Her research uses realworld data to perform health services/outcomes research and comparative effectivenessresearch for medications and implantable medical devices in patients with chronic disease.
She has produced critical insights to improve the health outcomes of patients with chronic
disease. Her work is internationally regarded for its methodological rigor and creativity. As shetackled important research questions, she used, promoted, and developed/tested various
methods to conduct valid studies including 1) data linkage, 2) design-based and analytic
methods for pharmacoepidemiologic studies, and 3) validation studies.

Speakers
Tobias Gerhard FISPE, Public Health Rutgers University, USA
Tobias Gerhard, BSPharm, PhD, FISPE, is an Associate Professor ofPharmacy and Epidemiology at Rutgers University and the Founding
Director of the Rutgers Center for Pharmacoepidemiology and Treatment
Science (PETS). His research interests focus on the development,
application, and evaluation of modern pharmacoepidemiologic methods
using large clinical and administrative datasets, particularly in the areasof mental health and drug-disease interactions. Dr. Gerhard is a Fellow
and past Board and Executive Committee Member of the International
Society for Pharmacoepidemiology and directs the course on Principlesof Pharmacoepidemiology during the ICPE pre-conference educationalsession. His work has been funded by NIA, NIMH, AHRQ, PCORI, as
well as by several foundations. Dr. Gerhard has received a NARSAD
Young Investigator Award from the Brain and Behavior Research Foundation and a NCDEU
New Investigator Award from the American Society of Clinical Psychopharmacology. Heserves on committees for FDA and the National Academies of Sciences, Engineering, andMedicine and has published over 70 peer-reviewed papers on pharmacoepidemiologic topics.

Ju-Young Shin, Sungkyunkwan University, South Korea
Dr. Ju-Young Shin is a current assistant professor at school of pharmacy,
SungKyunKwan University (SKKU). She also serves as an associate
editor of Pharmacoepidemiolgoy and Drug Safety (PDS). She received
her B.S. in pharmacy from Seoul National University, MPH in health policyand Ph.D. in pharmacoepidemiology from the Seoul National University
College of Medicine. She was a visiting fellow at university of South
Australia, and postdoctoral fellow at McGill University. She publishedmore than 90 peer-reviewed journal and published her study in British
Medical Journal (BMJ), twice, regarding the safety of antidepressants andADHD medication using 50 million Korean healthcare database. Her areaof research is a safety of psychotropic drugs, vaccine safety, methodology development, anddrug utilization review in the frail population. She is leading or co-leading several projects
sponsored by Korea Ministry of Food and Drug Safety, Ministry of Health and Welfare, Centerfor Disease Control and Prevention, National Research Foundations, and Pharmaceuticalcompanies. She was a past-team director at Korea Institute of Drug Safety and Risk
Management (KIDS) and led several epidemiological studies. She is now in charge of vicedirector in one of Korean regional pharmacovigilance center- pharmacist association. She alsoserves as a consultant for several Korean governmental committee including national
evidence-based collaborating agency (NECA), and KIDS. She has been a member ofInternational Society for Pharmacoepidemiology (ISPE) since 2007, and is currently a memberof board of directors of Korea society of Pharmacoepidemiology and Risk Management(KoPERM), Korea society of epidemiology, and Korea academy of social and managed carepharmacy.
Brian Strom FISPE, Rutgers University, USA
Brian L. Strom, M.D., M.P.H. is the Inaugural Chancellor of Rutgers
Biomedical and Health Sciences (RBHS) and the Executive Vice
President for Health Affairs at Rutgers University. RBHS is comprised ofeight schools and seven major centers/institutes, and includes academic,patient care, and research facilities. Dr. Strom was formerly theExecutive Vice Dean of Institutional Affairs, Founding Chair of theDepartment of Biostatistics and Epidemiology, Founding Director of theCenter for Clinical Epidemiology and Biostatistics, and Founding Directorof the Graduate Program in Epidemiology and Biostatistics, all at thePerelman School of Medicine of the University of Pennsylvania (Penn).
Although Dr. Strom's interests span many areas of clinical epidemiology,
his major research interest is in the field of pharmacoepidemiology, i.e., the application ofepidemiologic methods to the study of drug use and effects. He is recognized as a founder ofthis field and for his pioneer work in using large automated databases for research.